Headlines
-
Editor’s Choice: Natio Mother’s Day gifts that give twice
Thursday | Mar 6 2025NATIO is creating gift sets for Mother's Day, with $1 from every purchase going to Lighthouse Foundation to support its mission to end youth homelessness.
-
NSAIDs prevent dementia
Thursday | Mar 6 2025PEOPLE who use anti-inflammatory drugs over a long period of time may be at a lower risk of dementia regardless of the dosage, according to a Dutch study published in the Journal of the American Geriatrics Society.
-
CMO urges vaccinators to improve uptake
Wednesday | Mar 5 2025IN A letter to health professionals, Chief Medical Officer Professor Anthony Lawler expressed concern about declining influenza vaccine rates, urging vaccinators to focus on improving uptake as the flu season approaches.
-
AdPha welcomes IV fluid boost
Wednesday | Mar 5 2025HEALTH Minister Mark Butler has announced a $20 million government investment in increased local production of IV fluids in a move designed to end Australia's reliance on the product from overseas.
-
Travel telehealth and pharmacies team up
Wednesday | Mar 5 2025A NEW telehealth travel medicine service has launched in NSW, teaming up with pharmacies across the state to improve access to high-quality pre-travel healthcare.
-
Systems focus for WOD
Tuesday | Mar 4 2025WORLD Obesity Day (WOD) takes place today, with this year's theme shining a spotlight on the systems that shape our health: 'Changing systems.
-
Yindyamarra: AdPha’s vision for 2030
Tuesday | Mar 4 2025ADVANCED Pharmacy Australia (AdPha) has released its six-year strategic plan, with the patient at the heart of everything they do.
-
AD drug knocked back
Tuesday | Mar 4 2025The Therapeutic Goods Administration (TGA) has confirmed its initial decision from Oct 2024 not to register lecanemab in Australia for use as an amyloid-lowering therapy for the treatment of mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's dementia (early Alzheimer's disease).
-
PSA recognises NSW excellence
Monday | Mar 3 2025THE Pharmaceutical Society of Australia (PSA) has announced the winners of the PSA NSW Excellence Awards, recognising outstanding pharmacists who have demonstrated excellence in their practice and dedication to improving healthcare outcomes for their communities.
-
Arexvy safety data out
Monday | Mar 3 2025AUSVAXSAFETY has published the first Australian safety data on Arexvy respiratory syncytial virus (RSV) vaccination in people aged 60 years and older, reporting low adverse event rates.
